Listing Type:   | International Debt |
Listing Status:   | Delisted |
Listed:   | 24 Dec 2019 |
Delisted:   | 03 Nov 2023 |
Horizon Therapeutics Treasury DAC., a designated activity company, incorporated under the laws of Ireland, registered with the Irish Companies Registration office under company number 546291 and with its parent company registered office at Connaught House, 1st Floor, 1 Burlington Road, Dublin 4, Ireland.The Issuer is an indirect wholly-owned subsidiary of the Parent. The Issuer provides treasury services to other companies within the Horizon group. The Issuer’s registered office is located at 70 Sir John Rogerson’s Quay, Grand Canal Dock, Dublin 2, Ireland The Noteholder is an indirect subsidiary of the Parent. The Noteholder HZNP Finance Limitedprovides financing services to other companies within the Horizon group. The Noteholder’s registered office is located at H.P. House, 21 Laffan Street, Hamilton HM 09, Bermuda.
On 24 May 2022, the original promissory note of $867,040,436.27 due May 20,2026 was divided into two tranches - this security is the first tranche.
Horizon Therapeutics Treasury DAC. US$498,000,000 Tranche 1 – 3.28% Promissory Note due May 20, 2026.
Disclaimer and Privacy Policy Complaints Policy
Copyright © 2024 by Bermuda Stock Exchange. All rights reserved!
Questions or requests for information can be emailed to info@bsx.com